Cargando…
Antigenic variants of influenza B viruses isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons
BACKGROUND: Here, we genetically and antigenically analyzed influenza B viruses (IBVs) isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons. METHODS: A total of 68 IBVs (61 B/Yamagata/16/88‐like [B/Yamagata]‐lineage and 7 B/Victoria/2/87‐like [B/Victoria]‐lineage) were antigenicall...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182600/ https://www.ncbi.nlm.nih.gov/pubmed/31955521 http://dx.doi.org/10.1111/irv.12713 |
_version_ | 1783526260964589568 |
---|---|
author | Kato‐Miyashita, Sari Sakai‐Tagawa, Yuko Yamashita, Makoto Iwatsuki‐Horimoto, Kiyoko Ito, Mutsumi Tokita, Akifumi Hagiwara, Haruhisa Izumida, Naomi Nishino, Tamon Wada, Noriyuki Koga, Michiko Adachi, Eisuke Jubishi, Daisuke Yotsuyanagi, Hiroshi Kawaoka, Yoshihiro Imai, Masaki |
author_facet | Kato‐Miyashita, Sari Sakai‐Tagawa, Yuko Yamashita, Makoto Iwatsuki‐Horimoto, Kiyoko Ito, Mutsumi Tokita, Akifumi Hagiwara, Haruhisa Izumida, Naomi Nishino, Tamon Wada, Noriyuki Koga, Michiko Adachi, Eisuke Jubishi, Daisuke Yotsuyanagi, Hiroshi Kawaoka, Yoshihiro Imai, Masaki |
author_sort | Kato‐Miyashita, Sari |
collection | PubMed |
description | BACKGROUND: Here, we genetically and antigenically analyzed influenza B viruses (IBVs) isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons. METHODS: A total of 68 IBVs (61 B/Yamagata/16/88‐like [B/Yamagata]‐lineage and 7 B/Victoria/2/87‐like [B/Victoria]‐lineage) were antigenically and genetically characterized by using hemagglutination inhibition (HI) assays and phylogenetic analysis, respectively. The susceptibility of IBVs to neuraminidase (NA) inhibitors was assessed by using a fluorescence‐based NA inhibition assay. RESULTS: All 61 B/Yamagata‐lineage isolates were genetically closely related to B/Phuket/3073/2013, the vaccine strain for these two seasons. Eleven B/Yamagata‐lineage isolates tested were antigenically similar to B/Phuket/3073/2013 by the HI test. Seven B/Victoria‐lineage isolates were genetically closely related to B/Texas/02/2013, the WHO‐recommended vaccine strain for the 2017‐2018 season; however, they were antigenically distinct from B/Texas/02/2013 with an eightfold or 16‐fold difference in HI titer. Of these 7 isolates, 4 possessed a two‐amino‐acid deletion at positions 162 and 163 in hemagglutinin (HA) and the other 3 had a three‐amino‐acid deletion at positions 162‐164 in HA. Importantly, the variants with the three‐amino‐acid deletion appeared to be antigenically different from the B/Colorado/06/2017 virus with the two‐amino‐acid deletion, the vaccine strain for the 2018‐2019 season with a fourfold or eightfold difference in HI titer. One B/Yamagata‐lineage isolate carrying a G407S mutation in its NA showed a marked reduction in susceptibility to zanamivir, peramivir, and laninamivir. CONCLUSIONS: These results highlight the need for continued monitoring for the prevalence of the antigenic variant with the three‐amino‐acid deletion and the variant with reduced NA inhibitor susceptibility. |
format | Online Article Text |
id | pubmed-7182600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71826002020-05-01 Antigenic variants of influenza B viruses isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons Kato‐Miyashita, Sari Sakai‐Tagawa, Yuko Yamashita, Makoto Iwatsuki‐Horimoto, Kiyoko Ito, Mutsumi Tokita, Akifumi Hagiwara, Haruhisa Izumida, Naomi Nishino, Tamon Wada, Noriyuki Koga, Michiko Adachi, Eisuke Jubishi, Daisuke Yotsuyanagi, Hiroshi Kawaoka, Yoshihiro Imai, Masaki Influenza Other Respir Viruses Original Articles BACKGROUND: Here, we genetically and antigenically analyzed influenza B viruses (IBVs) isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons. METHODS: A total of 68 IBVs (61 B/Yamagata/16/88‐like [B/Yamagata]‐lineage and 7 B/Victoria/2/87‐like [B/Victoria]‐lineage) were antigenically and genetically characterized by using hemagglutination inhibition (HI) assays and phylogenetic analysis, respectively. The susceptibility of IBVs to neuraminidase (NA) inhibitors was assessed by using a fluorescence‐based NA inhibition assay. RESULTS: All 61 B/Yamagata‐lineage isolates were genetically closely related to B/Phuket/3073/2013, the vaccine strain for these two seasons. Eleven B/Yamagata‐lineage isolates tested were antigenically similar to B/Phuket/3073/2013 by the HI test. Seven B/Victoria‐lineage isolates were genetically closely related to B/Texas/02/2013, the WHO‐recommended vaccine strain for the 2017‐2018 season; however, they were antigenically distinct from B/Texas/02/2013 with an eightfold or 16‐fold difference in HI titer. Of these 7 isolates, 4 possessed a two‐amino‐acid deletion at positions 162 and 163 in hemagglutinin (HA) and the other 3 had a three‐amino‐acid deletion at positions 162‐164 in HA. Importantly, the variants with the three‐amino‐acid deletion appeared to be antigenically different from the B/Colorado/06/2017 virus with the two‐amino‐acid deletion, the vaccine strain for the 2018‐2019 season with a fourfold or eightfold difference in HI titer. One B/Yamagata‐lineage isolate carrying a G407S mutation in its NA showed a marked reduction in susceptibility to zanamivir, peramivir, and laninamivir. CONCLUSIONS: These results highlight the need for continued monitoring for the prevalence of the antigenic variant with the three‐amino‐acid deletion and the variant with reduced NA inhibitor susceptibility. John Wiley and Sons Inc. 2020-01-19 2020-05 /pmc/articles/PMC7182600/ /pubmed/31955521 http://dx.doi.org/10.1111/irv.12713 Text en © 2020 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Kato‐Miyashita, Sari Sakai‐Tagawa, Yuko Yamashita, Makoto Iwatsuki‐Horimoto, Kiyoko Ito, Mutsumi Tokita, Akifumi Hagiwara, Haruhisa Izumida, Naomi Nishino, Tamon Wada, Noriyuki Koga, Michiko Adachi, Eisuke Jubishi, Daisuke Yotsuyanagi, Hiroshi Kawaoka, Yoshihiro Imai, Masaki Antigenic variants of influenza B viruses isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons |
title | Antigenic variants of influenza B viruses isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons |
title_full | Antigenic variants of influenza B viruses isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons |
title_fullStr | Antigenic variants of influenza B viruses isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons |
title_full_unstemmed | Antigenic variants of influenza B viruses isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons |
title_short | Antigenic variants of influenza B viruses isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons |
title_sort | antigenic variants of influenza b viruses isolated in japan during the 2017‐2018 and 2018‐2019 influenza seasons |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182600/ https://www.ncbi.nlm.nih.gov/pubmed/31955521 http://dx.doi.org/10.1111/irv.12713 |
work_keys_str_mv | AT katomiyashitasari antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT sakaitagawayuko antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT yamashitamakoto antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT iwatsukihorimotokiyoko antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT itomutsumi antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT tokitaakifumi antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT hagiwaraharuhisa antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT izumidanaomi antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT nishinotamon antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT wadanoriyuki antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT kogamichiko antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT adachieisuke antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT jubishidaisuke antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT yotsuyanagihiroshi antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT kawaokayoshihiro antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons AT imaimasaki antigenicvariantsofinfluenzabvirusesisolatedinjapanduringthe20172018and20182019influenzaseasons |